Criteria adopted in different models of public healthcare systems for the evaluation of reimbursement recommendations of orphan drugs: a scoping review.
Introdução: Access to drugs for rare diseases constitutes a challenge to healthcare systems, especially those with public funding. The difficulty of conducting robust clinical trials limits the quality of evidence and elevates the cost of development, later translated into the drug's prices. Th...
Αποθηκεύτηκε σε:
Κύριοι συγγραφείς: | , , , |
---|---|
Μορφή: | Βιβλίο |
Έκδοση: |
Instituto Nacional de Assistência Farmacêutica e Farmacoeconomia,
2023-11-01T00:00:00Z.
|
Θέματα: | |
Διαθέσιμο Online: | Connect to this object online. |
Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|
Διαδίκτυο
Connect to this object online.3rd Floor Main Library
Ταξινομικός Αριθμός: |
A1234.567 |
---|---|
Αντίγραφο 1 | Στη βιβλιοθήκη |